Press Releases

Kite Pharma to Host Investor Day on June 23, 2015

SANTA MONICA, Calif., June 16, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE), today announced that the Company will host a live webcast in conjunction with its Investor Day on Tuesday, June 23, 2015 at 12:00p.m. ET in New York, NY.

The live audio webcast and the accompanying slide presentations can be accessed through the Calendar of Events section of the Company's website at A replay of the webcast will be available on the Company's website for two weeks following the event.

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA.

CONTACT: For Media:

         Justin JacksonBurns McClellan


         For Investor Day Inquiries:

         Ami BavishiBurns McClellan

         212-213-0006, ext. 344

Kite Pharma, Inc.

News Provided by Acquire Media